Dual antiplatelet therapy in stroke and ICAS

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neurology

• Publication date

  2015-09-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0000000000001972PMID 26330567PMCID PMC4603889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China: The Chinese Intracranial Atherosclerosis (CICAS) Study

  2014cited by this paper
• Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

  2013influential reference
• Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack: An Updated Systematic Review and Meta-Analysis

  2013influential reference
• Dual antiplatelet therapy in acute transient ischemic attack and minor stroke.

  2013cited by this paper
• A little good...

  2013cited by this paper
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design

  2013cited by this paper
• Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

  2012cited by this paper
• Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.

  2010cited by this paper
• Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event.

  2010cited by this paper
• Intracranial atherosclerotic disease: An update

  2009cited by this paper
• Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial.

  2007cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial

  2005cited by this paper
• A standardized method for measuring intracranial arterial stenosis.

  2000cited by this paper
• Use of Transcranial Doppler Ultrasound to Predict Outcome in Patients With Intracranial Large-Artery Occlusive Disease

  2000cited by this paper
• An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

  1993cited by this paper

• Early antiplatelet treatment for minor stroke following thrombolysis: Insights from the Early Antiplatelet for Minor Stroke following Thrombolysis trial

  2026cites this paper
• The effect of dual antiplatelet therapy in different patterns of watershed infarction: Subgroup analysis of the INSPIRES trial.

  2026cites this paper
• Dual Antiplatelet Therapy After Ischemic Stroke Stratified by Intracranial or Extracranial Atherosclerotic Stenosis

  2025cites this paper
• Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial.

  2025cites this paper
• Addressing important challenges in global stroke care: World Stroke Organization scientific statements

  2025cites this paper
• Influence of Bi doping on electronic structure and optical behavior of congruent LiNbO3: Insights from density functional theory

  2025cites this paper
• Unveiling the dual threat: combined elevated triglyceride-glucose index and intracranial arterial stenosis burden for enhanced stroke risk stratification

  2025cites this paper
• Low-grade Inflammation Score: a Risk Factor for Stroke Recurrence in Patients With Intracranial Atherosclerotic Stenosis

  2025cites this paper
• Evaluation of Intracranial Atherosclerotic Stenosis Burden, the Use of Dual Antiplatelet Therapy and Stroke Recurrence in Patients with Minor Stroke.

  2025cites this paper
• Residual lipoprotein(a)-associated risk in patients with stroke or transient ischemic attack.

  2025cites this paper
• Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study

  2025cites this paper
• Cilostazole versus clopidogrel in acute large-vessel moderate and moderate-to-severe ischemic stroke: a randomized controlled trial

  2025cites this paper
• CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial

  2025cites this paper
• Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial

  2025cites this paper
• Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI

  2025cites this paper
• Early Neurologic Deterioration and Efficacy of Dual Antiplatelet in Anterior Versus Posterior Circulation Stroke

  2025cites this paper
• Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

  2025cites this paper
• Ticagrelor plus aspirin versus cilostazol plus aspirin in the acute-phase treatment of large-vessel minor stroke or TIA: a randomized controlled multi-center trial, the TACTIS trial.

  2025cites this paper
• Efficacy and safety of dual-antiplatelet therapy with high-intensity statin versus single-antiplatelet therapy with high-intensity statin in patients with stroke or high-risk mini-stroke of atherosclerotic origin: A cohort study

  2025cites this paper
• Optimal Medical Management of Atherosclerotic Intracranial Stenosis.

  2024cites this paper
• Evaluation of the effect on stroke mechanism, stroke recurrence and clinical outcome in stroke patients with basilar artery atherosclerosis: A single centre retrospective observational study

  2024cites this paper
• TICA-CLOP STUDY: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke, a Randomized Controlled Multi-Center Trial

  2024cites this paper
• Efficacy and safety of drug-eluting stents versus bare-metal stents in symptomatic intracranial and vertebral artery stenosis: a meta-analysis

  2024cites this paper
• Dual Antiplatelet Versus Alteplase for Early Neurologic Deterioration in Minor Stroke With Versus Without Large Vessel Occlusion: Prespecified Post Hoc Analysis of the ARAMIS Trial

  2024cites this paper
• Peripheral Lymphocyte-to-Monocyte Ratio as a Predictive Factor for Early Neurological Deterioration in Patients with Acute Ischemic Stroke

  2024cites this paper
• Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial

  2024cites this paper
• The guardian of intracranial vessels: Why the pericyte?

  2024cites this paper
• ACR Appropriateness Criteria® Cerebrovascular Diseases-Stroke and Stroke-Related Conditions.

  2024cites this paper
• Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia

  2024cites this paper
• Balloon angiopLasty for intracranial Atherosclerotic minor Stroke/TIA (BLAST): study protocol for a multicenter prospective cohort study

  2024cites this paper
• THE STUDY OF RISK FACTOR AND STRATEGIES FOR PREVENTION OF RECURRENT ISCHEMIC STROKE :A COMPREHENSIVE SYSTEMATIC REVIEW

  2024cites this paper
• Stroke in Asia

  2024cites this paper
• Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial

  2024cites this paper
• STENOSIS: Long-term single versus dual antiplatelet therapy in patients with ischaemic stroke due to intracranial atherosclerotic disease – a randomised trial

  2024cites this paper
• A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients—A Review PART II—Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory

  2024cites this paper
• European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke

  2024cites this paper
• Roundtable of Academia and Industry for Stroke Prevention: Prevention and Treatment of Large-Vessel Disease.

  2024cites this paper
• Factors related to unfavorable outcome in minor ischemic stroke.

  2023cites this paper
• Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.

  2023cites this paper
• An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke

  2023cites this paper
• Plaque Evolution and Vessel Wall Remodeling of Intracranial Arteries: A Prospective, Longitudinal Vessel Wall MRI Study

  2023cites this paper
• Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE‐2

  2023cites this paper
• Intracranial arterial stenosis and recurrence in stroke patients with different risk stratifications by Essen stroke risk score

  2023cites this paper
• Angiography-based hemodynamic features predict recurrent ischemic events after angioplasty and stenting of intracranial vertebrobasilar atherosclerotic stenosis

  2023cites this paper
• High-Sensitivity C-reactive Protein and Intracranial Arterial Stenosis Predicted Recurrent Stroke and Dependence or Death in Minor Stroke or Transient Ischemic Attack

  2023cites this paper
• Determinants and Temporal Trends of Dual Antiplatelet Therapy After Mild Noncardioembolic Stroke

  2023cites this paper
• Minor stroke patients with mild-moderate diastolic blood pressure derive greater benefit from dual antiplatelet therapy

  2023cites this paper
• Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke

  2023cites this paper
• Central Retinal Artery Occlusion: A Review of Pathophysiological Features and Management

  2023cites this paper
• Intracranial atherosclerotic disease: current management strategies

  2023cites this paper
• Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial

  2023cites this paper
• Hemodynamic outcomes of stenting for vertebrobasilar insufficiency in patients with a low flow state

  2023cites this paper
• [Optimization of secondary prevention in patients with high-risk atherothrombotic ischemic stroke or transient ischemic attacks].

  2023cites this paper
• The 2023 Taiwan Stroke Society Guidelines for the management of patients with intracranial atherosclerotic disease

  2023cites this paper
• Dual Versus Mono Antiplatelet Therapy in Patients with Acute Mild-to-Moderate Stroke: A Multicentre Perspective Cohort Study

  2023cites this paper
• Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update

  2023cites this paper
• Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage

  2023cites this paper
• Efficacy and safety of low dose aspirin plus clopidogrel in the treatment of elderly patients with symptomatic intracranial artery stenosis

  2023cites this paper
• A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization

  2023cites this paper
• Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)

  2023cites this paper
• Composition, Treatment, and Outcomes by Radiologically Defined Thrombus Characteristics in Acute Ischemic Stroke

  2023cites this paper
• Advanced age is associated with increased adverse outcomes in patients undergoing middle cerebral artery stenting

  2023cites this paper
• A nomogram for predicting the in-hospital risk of recurrence among patients with minor non-cardiac stroke

  2022cites this paper
• Dual Antiplatelet Therapy in the Management of Acute Minor Ischemic Stroke and High-Risk Transient Ischemic Attack: An Expert Consensus Statement From Taiwan Stroke Society and Taiwan Society of Emergency Medicine.

  2022cites this paper
• Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis

  2022cites this paper
• A Decade On: The Evolving Renaissance in Intracranial Atherosclerotic Disease

  2022cites this paper
• Increased serum concentrations of Mesencephalic astrocyte-derived neurotrophic factor in patients and rats with ischemic stroke.

  2022cites this paper
• Elevated hs-CRP and Symptomatic Intracranial/Extracranial Artery Stenosis Predict Stroke Recurrence after Acute Ischemic Stroke or TIA

  2022cites this paper
• Dual anti-platelet therapy for secondary prevention in intracranial atherosclerotic disease: a network meta-analysis

  2022cites this paper
• Circulating MicroRNAs as Potential Biomarkers for Ischemic Stroke in Patients with Asymptomatic Intracranial Artery Stenosis

  2022cites this paper
• Hemodynamic and Geometric Risk Factors for In-Stent Restenosis in Patients with Intracranial Atherosclerotic Stenosis

  2022cites this paper
• Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke

  2022cites this paper
• Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.

  2022cites this paper
• EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer

  2022cites this paper
• Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III)

  2022cites this paper
• European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease

  2022cites this paper
• Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies.

  2022cites this paper
• Prognosis and antiplatelet therapy of small single subcortical infarcts in penetrating artery territory: a post hoc analysis of the Third China National Stroke Registry

  2022cites this paper
• Coexistent cerebral small vessel disease and multiple infarctions predict recurrent stroke

  2022cites this paper
• P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis.

  2022cites this paper
• Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory

  2022cites this paper
• Dual versus mono antiplatelet therapy in mild‐to‐moderate stroke during hospitalization

  2022cites this paper
• Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment.

  2022cites this paper
• The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease.

  2021cites this paper
• Commentary: Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial.

  2021cites this paper
• Quantification of intracranial arterial stenotic degree evaluated by high-resolution vessel wall imaging and time-of-flight MR angiography: reproducibility, and diagnostic agreement with DSA

  2021cites this paper
• Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes

  2021cites this paper
• Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review

  2021cites this paper
• Carotid Stenosis and Recurrent Ischemic Stroke

  2021cites this paper
• A Comparison of Safety and Effectiveness Between Wingspan and Neuroform Stents in Patients With Middle Cerebral Artery Stenosis

  2021cites this paper
• Do We Need Precision Medicine in Stroke?

  2021cites this paper
• Pharmacodynamics and Pharmacokinetics of Stroke Therapy

  2021cites this paper
• Therapeutic Potential of Remote Ischemic Conditioning in Vascular Cognitive Impairment

  2021cites this paper
• Acute Secondary Prevention of Ischemic Stroke: Overlooked No Longer

  2021cites this paper
• Effect of Ginkgolide in Ischemic Stroke patients with large Artery Atherosclerosis: Results from a randomized trial

  2021cites this paper
• Development and validation of visual grading system for stenosis in intracranial atherosclerotic disease on time-of-flight magnetic resonance angiography

  2021cites this paper
• Higher early recurrence risk and potential benefit of dual antiplatelet therapy for minor stroke with watershed infarction: subgroup analysis of CHANCE

  2020cites this paper
• Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke

  2020cites this paper
• Five-Year Prognosis After TIA or Minor Ischemic Stroke in Asian and Non-Asian Populations

  2020cites this paper
• Prevalence, prognosis, and treatment of atherosclerotic intracranial stenosis in Caucasians

  2020influential citation